Skip to content

Prevention of Deep Vein Thrombosis with Electrical Muscle Stimulator

Exploratory study on prevention of deep vein thrombosis after gastrointestinal surgery using an electrical muscle stimulator

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1040250039
Enrollment
30
Registered
2025-05-28
Start date
2025-04-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal diseases requiring abdominal surgery Gastrointestinal Diseases

Interventions

Minor invasive muscle stimulation using electrical muscle stimulation devices on the lower extremities
D011211
Electric Power Supplies

Sponsors

Nakaya Seiichi
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age 60 or older at the time of consent 2. Patients undergoing abdominal surgery in the Department of Gastroenterology and Gastrointestinal Surgery 3. Patients requiring bed rest for more than 6 hours after surgery 4. Patients requiring hospitalization until the third postoperative day 5. Patients who are at intermediate risk or high risk for deep vein thrombosis according to the guidelines 6. Patients who are willing to participate in this study and whose consent can be obtained in writing from the patients themselves.

Exclusion criteria

Exclusion criteria: 1. Patients whose will cannot be confirmed 2. Patients with preoperative deep vein thrombosis as determined by preoperative examination 3. Patients participating in other clinical trials related to deep vein thrombosis 4. Patients with an implanted pacemaker 5. Patients with severe cardiac dysfunction 6. Patients who are allergic to contrast media, iodine allergy, asthma, hyperthyroidism, etc. and cannot undergo contrast media examinations 7. Patients using wearable medical electrical equipment such as electrocardiographs 8. Patients with skin sensory disturbance or abnormality (infection, dermatitis, wound, etc.) 9. Patients with blood circulation disorder in the lower limbs 10. Patients with epilepsy 11. Patients with sensory disturbance due to severe peripheral circulatory disturbance caused by diabetes mellitus, etc. (12) Patients with serious infections. 12. Patients suspected to have serious infections 13. Patients with coexisting diseases requiring bed rest 14. Patients with acute pain due to fracture, sprain, or separation of the lower limb 15. Patients with coexisting osteoporosis 16. Patients with uncontrollable abnormal blood pressure 17. Patients with metal, plastic, silicone, etc. implanted in the area of use 18. Patients with tattoos in the area of use. 19. Patients whose cognitive function or mental status is deemed inappropriate by the principal investigator (or co-investigator).

Design outcomes

Primary

MeasureTime frame
Incidence of deep vein thrombosis

Secondary

MeasureTime frame
1. Safety of electrical muscle stimulators 2. Completion rate of electrical muscle stimulators 3. Incidence of adverse events due to electrical stimulation 4. Trends in D-Dimer values

Contacts

Public ContactSeiichi Nakaya

Nagoya City University Midori Municipal Hospital

nakaya22@med.nagoya-cu.ac.jp+81-52-892-1331

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026